Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5114/ait.2020.101007 http://scihub22266oqcxt.onion/10.5114/ait.2020.101007 33242934!10183979!33242934     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33242934&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 251.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Anaesthesiol+Intensive+Ther 2020 ; 52 (5): 373-376 Nephropedia Template TP {{tp|p=33242934|t=2020. Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure A single-centre case series |pdf=|usr=}}{{33242934}} gab.com Text Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure A single-centre case series JO: Anaesthesiol Intensive Ther http://www.kidney.de/pget.php?&tw=1&pmid=33242934 #FOAvip INTRODUCTION: A high-flow nasal cannula (HFNC) is an alternative device for oxygena-tion, which improves gas exchange and reduces the work of breathing. Postextubation respiratory failure causes increased morbidity and mortality. HFNC has been widely employed during the COVID-19 pandemic. The purpose of this paper is to report a single-centre experience on the effectiveness and safety of HFNC in weaning COVID-19 patients. MATERIAL AND METHODS: Nine patients showed severe acute respiratory failure and interstitial pneumonia due to SARS-CoV-2. After mechanical ventilation (5 Helmet CPAP, 4 invasive mechanical ventilation), they were de-escalated to HFNC. Settings were: 34-37 degrees C, flow from 50 to 60 L min-1. FiO2 was set to achieve appropriate SpO2. RESULTS: Nine patients (4 females; age 63 +/- 13.27 years; BMI 27.2 +/- 4.27) showed a baseline PaO2/FiO2 of 109 +/- 45 mm Hg. After a long course of ventilation all patients improved (PaO2/FiO2 336 +/- 72 mm Hg). Immediately after initiation of HFNC (2 hours), PaO2/FiO2 was 254 +/- 69.3 mm Hg. Mean ROX index at two hours was 11.17 (range: 7.38-14.4). It was consistent with low risk of HFNC failure. No difference was observed on lactate. After 48 hours of HFNC oxygen therapy (day 3), mean PaO2/FiO2 increased to 396 +/- 83.5 mm Hg. All patients recovered from respiratory failure after 7 +/- 4.1 days. CONCLUSIONS: HFNC might be helpful in weaning COVID-19 respiratory failure. Effectiveness and comfort should be assessed between 2 and 48 hours. Clinical outcomes, oxygenation, and ROX index should be considered, to rule out the need for intubation. Further evidence is required for firm conclusions. Twit Text FOAVip Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure A single-centre case series ????Anaesthesiol Intensive Ther http://www.kidney.de/pget.php?&tw=1&pmid=33242934 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33242934 #FOAvip English Wikipedia <ref>{{Cite pmid|33242934}}</ref> Clinical outcomes of high-flow nasal cannula in COVID-19 associated postextubation respiratory failure A single-centre case series #MMPMID33242934 Simioli F; Annunziata A; Langella G; Polistina GE; Martino M; Fiorentino G Anaesthesiol Intensive Ther 2020[]; 52 (5): 373-376 PMID33242934show ga INTRODUCTION: A high-flow nasal cannula (HFNC) is an alternative device for oxygena-tion, which improves gas exchange and reduces the work of breathing. Postextubation respiratory failure causes increased morbidity and mortality. HFNC has been widely employed during the COVID-19 pandemic. The purpose of this paper is to report a single-centre experience on the effectiveness and safety of HFNC in weaning COVID-19 patients. MATERIAL AND METHODS: Nine patients showed severe acute respiratory failure and interstitial pneumonia due to SARS-CoV-2. After mechanical ventilation (5 Helmet CPAP, 4 invasive mechanical ventilation), they were de-escalated to HFNC. Settings were: 34-37 degrees C, flow from 50 to 60 L min-1. FiO2 was set to achieve appropriate SpO2. RESULTS: Nine patients (4 females; age 63 +/- 13.27 years; BMI 27.2 +/- 4.27) showed a baseline PaO2/FiO2 of 109 +/- 45 mm Hg. After a long course of ventilation all patients improved (PaO2/FiO2 336 +/- 72 mm Hg). Immediately after initiation of HFNC (2 hours), PaO2/FiO2 was 254 +/- 69.3 mm Hg. Mean ROX index at two hours was 11.17 (range: 7.38-14.4). It was consistent with low risk of HFNC failure. No difference was observed on lactate. After 48 hours of HFNC oxygen therapy (day 3), mean PaO2/FiO2 increased to 396 +/- 83.5 mm Hg. All patients recovered from respiratory failure after 7 +/- 4.1 days. CONCLUSIONS: HFNC might be helpful in weaning COVID-19 respiratory failure. Effectiveness and comfort should be assessed between 2 and 48 hours. Clinical outcomes, oxygenation, and ROX index should be considered, to rule out the need for intubation. Further evidence is required for firm conclusions. |*Catheterization[MESH] |*Nasal Cavity[MESH] |Adult[MESH] |Aged[MESH] |Airway Extubation/adverse effects/*methods[MESH] |COVID-19/*complications/therapy[MESH] |Cross-Sectional Studies[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Noninvasive Ventilation[MESH] |Oxygen Inhalation Therapy/*methods[MESH] |Pneumonia/etiology/therapy[MESH] |Respiratory Distress Syndrome/etiology/therapy[MESH] |Respiratory Insufficiency/*etiology/*therapy[MESH] |Treatment Outcome[MESH]Clinical outcomes of high-flow nasal cannula in COVID-19 associated p(epmc).pdf DeepDyve Pubget Overpricing